Results 21 to 30 of about 6,425 (142)

Soluble Suppression of Tumorigenicity 2 (sST2) in Patients with Predominantly Decompensated Right Heart Failure—A Prospective Observational Study [PDF]

Journal of Clinical Medicine, 2023
Anja Haase-Fielitz, Michael Lichtenauer, Marwin Bannehr   +2 more
exaly   +2 more sources

Serum Soluble ST2 Is a Valuable Prognostic Biomarker in Patients With Acute Heart Failure

Frontiers in Cardiovascular Medicine, 2022
BackgroundThis study aimed to investigate the clinical utility of different soluble suppression of tumorigenicity 2 (sST2) levels in assessing the severity and prognosis of patients with acute heart failure (AHF).MethodsThis was a prospective cohort ...
Zeyu Wang, Xin Pan, Hong Xu, You Wu, Xiaomin Jia, Yiling Fang, Yi Lu, Yawei Xu, Ji Zhang, Yang Su   +9 more
doaj   +1 more source

Contemporary Risk Stratification After Myocardial Infarction in the Community: Performance of Scores and Incremental Value of Soluble Suppression of Tumorigenicity‐2

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
BackgroundCurrent American Heart Association/American College of Cardiology guidelines recommend the GRACE (Global Registry of Acute Coronary Events) and TIMI (Thrombolysis in Myocardial Infarction) scores to assess myocardial infarction (MI) prognosis ...
Yariv Gerber, Susan A. Weston, Maurice Enriquez‐Sarano, Allan S. Jaffe, Sheila M. Manemann, Ruoxiang Jiang, Véronique L. Roger   +6 more
doaj   +1 more source

Diagnostic Value of Soluble Suppression of Tumorigenicity-2 for Heart Failure

Chinese Medical Journal, 2016
Background: Many studies have explored the diagnostic performance of soluble suppression of tumorigenicity-2 (sST2) for heart failure (HF), but the results are inconsistent.
Dong-Hui Huang, Hao Sun, Jing-Pu Shi
doaj   +1 more source

Performance Evaluation of AFIAS ST2 and Ichroma ST2 Assays in Comparison with Presage ST2 Assay

Reviews in Cardiovascular Medicine, 2023
Background: Elevated soluble suppression of tumorigenicity 2 (sST2) levels may predict mortality in heart failure (HF) patients. The AFIAS ST2 assay (AFIAS ST2, Boditech Med Inc., Chuncheon, Korea) and ichroma ST2 assay (ichroma ST2, Boditech Med Inc ...
Hanah Kim, Tae-Hwan Lee, Mina Hur, Hyun-Joong Kim, Hyun Suk Yang, Kyeong Ryong Lee, Salvatore Di Somma   +6 more
doaj   +1 more source

Serum ST2 as an early predictor of heart failure in pediatric congenital heart disease. [PDF]

Zagazig University Medical Journal
Background: Heart failure (HF) is a serious consequence that can have varying effects on newborns and children with congenital heart disease (CHD). The soluble isoform of tumor suppression-2 (sST2) has become an interesting promising biomarker of heart ...
Marwa Mohammed Rashad, Abdulmalik Shoubar, Eman Elmoghazy, marwa Hussien   +3 more
doaj   +1 more source

Evaluation of serum interleukin-33 and soluble suppression of tumorigenicity 2 (sST2) receptors in patients with and without periodontal disease

Indian Journal of Dental Research, 2022
Context: Interleukin-33 and its receptor soluble suppression of tumorigenicity 2 (sST2) play an important role in inflammation and its role in periodontal disease is yet unclear.
Himadri Singh, Abhinav Singh, Rohit Saluja   +2 more
doaj   +1 more source

STADE‐HF (sST2 As a help for management of HF): a pilot study

ESC Heart Failure, 2020
Aims Biomarkers are not recommended until now to guide the management of patients with heart failure (HF). Soluble suppression of tumorigenicity 2 (sST2) appears as a promising biomarker. The current study considered pre‐discharged sST2 values as a guide
Fabien Huet, Jean Nicoleau, Anne‐Marie Dupuy, Corentin Curinier, Cyril Breuker, Audrey Castet‐Nicolas, Manuela Lotierzo, Eran Kalmanovich, Laetitia Zerkowski, Mariama Akodad, Jérôme Adda, Audrey Agullo, Florence Leclercq, Jean‐Luc Pasquie, Pascal Battistella, Camille Roubille, Pierre Fesler, Grégoire Mercier, Guillaume Bourel, Jean‐Paul Cristol, François Roubille   +20 more
doaj   +1 more source

CAQ Corner: Basic concepts of transplant immunology

, 2022
Liver Transplantation, EarlyView.
Amanda Cheung, Josh Levitsky
wiley   +1 more source

From energy provision to protein synthesis: Tunnelling nanotubes as mediators of intercellular metabolic cooperation in cancer

FEBS Open Bio, EarlyView.
The cytoskeleton‐mediated transport of mitochondria via tunnelling nanotubes restores respiration, increases ATP production, rescues cells from apoptosis, activates the AKT/mTOR signalling pathway, promotes cell migration and invasiveness, contributes to cancer progression and treatment resistance.
Stanislava Martínková, Jan Trnka
wiley   +1 more source